Tilray | TRLY - 债务利息支出

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 4.62B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	债务利息支出	更改		日
Akebia Therapeutics	362.52M		357.69M	2026-03
Alaunos Therapeutics	USD 1.07M		215K	2023-06
Aurora Cannabis	CAD 230K		1.88M	2026-03
Avita Medical	AUD 1.25M		100K	2025-06
Canopy Growth	CAD 12.31M		4.97M	2026-03
Cronos Group	USD 0		7K	2024-09
Dianthus Therapeutics	USD 4.44M		263K	2024-09
Divis Laboratories Ltd	INR 60M		0	2026-03
Ionis Pharmaceuticals	USD 18M		1000K	2026-06
IQVIA Holdings	USD 192M		1000K	2026-03
Knight Therapeutics	CAD 3.92M		1.56M	2025-12
Moderna	USD 10.96B		527M	2026-06
Organigram Holdings	CAD 179K		127K	2025-03
Organon & Co	USD 111M		17M	2026-03
Revvity	USD 24.72M		1.2M	2026-03
Tectonic Therapeutic	USD 246.58M		246.56M	2026-03
Tilray	USD 6.7M		2.73M	2025-06
Viatris	USD 120.1M		500K	2026-03
Xeris Pharmaceuticals	USD 6.88M		269K	2026-03
Zealand Pharma A/S	7.07M		74K	2025-12